// you’re reading...

General Biotechnology

Faster Entry Sought for Generics

By Yali ⋅ October 6, 2003 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Faster Entry Sought for Generics
Despite efforts to speed up approval of generic drugs, Americans still spend billions extra for prescriptions because of delays engineered by brand-name pharmaceutical companies. Pending legislation could help.

Print This Post

Discussion

No comments for “Faster Entry Sought for Generics”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com